Q1 2023
Released May 3, 2023, after the close
10-Q filed May 4, 2023, 34 days after period end · 0001653477-23-000037
Q1 2023 · 10-Q
Revenue$392.60M$392.60M +2.6% vs Q1 2022+2.3% vs Q4 2022
Net Income$50.70M$50.70M −16.6% vs Q1 2022+225.0% vs Q4 2022
EPS Diluted$1.35$1.35 −12.9% vs Q1 2022no prior Q4 2022 on file
Gross Profit$130,400,000−5.4%
Operating Income$103,900,000−12.7%
Operating Cash Flow$5,300,000−78.2%
Free Cash Flowderived-$20,100,000N/M
Margins · derived
Gross margin33.2%−2.8 pt vs Q1 2022
Operating margin26.5%−4.6 pt vs Q1 2022
Net margin12.9%−3.0 pt vs Q1 2022
What the release said
The release
Same quarter
| Metric | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|---|
| Revenue | $392.60M | $382.80M | $320.30M | $288.20M |
| Net Income | $50.70M | $60.80M | $48.70M | $45.30M |
| EPS Diluted | $1.35 | $1.55 | $1.20 | $1.08 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Ingevity Corp · CIK 1653477 · Engraved from SEC EDGAR